Lescol Xl

Fluvastatin, the active ingredient in Lescol XL, is a HMG‑CoA reductase inhibitor presented as an oral tablet for oral use. It lowers elevated cholesterol and triglyceride levels and is prescribed for adults at risk of cardiovascular disease. The medication is indicated for the management of hypercholesterolemia, hyperlipidemia, and for primary prevention of cardiovascular events in patients with established risk factors.

GNH USA supplies Lescol XL as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides reliable global distribution.

Lescol XL (fluvastatin) is used to manage disorders of lipid metabolism and to reduce cardiovascular risk.

- Hypercholesterolemia: reduces low‑density lipoprotein (LDL) cholesterol and total cholesterol levels. - Hyperlipidemia: lowers triglycerides and improves overall lipid profile. - Cardiovascular risk reduction: helps prevent myocardial infarction, stroke and related events in patients with elevated risk.

Fluvastatin may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Gastrointestinal discomfort: nausea, abdominal pain or dyspepsia. - Myalgia: muscle aches without weakness. - Elevated liver enzymes: transient increase in ALT or AST.

Serious or Rare Side Effects: - Rhabdomyolysis: severe muscle breakdown with possible renal impairment. - Hepatotoxicity: marked elevation of liver transaminases or jaundice. - Allergic reactions: rash, pruritus, angioedema or anaphylaxis.

Before initiating Lescol XL, clinicians should consider several safety and handling precautions.

- Liver function assessment: obtain baseline ALT/AST and monitor periodically. - Renal impairment: adjust use in patients with severe renal dysfunction. - Drug interactions: review concomitant medications that affect statin metabolism. - Pregnancy and lactation: avoid use unless potential benefit justifies potential risk. - Patient counseling: advise on reporting unexplained muscle pain or weakness. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Fluvastatin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole): may markedly increase fluvastatin plasma levels. - Gemfibrozil: combined use raises risk of myopathy and rhabdomyolysis. - Cyclosporine: enhances statin exposure and muscle toxicity.

Moderate Interactions (Monitor Closely): - Anticoagulants (warfarin): fluvastatin may potentiate anticoagulant effect, requiring INR monitoring. - Antidiabetic agents (e.g., insulin, sulfonylureas): statins can affect glucose control. - Niacin: may increase risk of hepatotoxicity when used together.